Skip to main content

Advertisement

Log in

ASO Author Reflections: Adding Value to Multidisciplinary Care by Incorporating Structured Surgeon Survey Assessment of the Effect of Neoadjuvant Therapies on Melanoma Operations

  • ASO Author Reflections
  • Published:
Annals of Surgical Oncology Aims and scope Submit manuscript
  • 1 Altmetric

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Dummer R, Hauschild A, Santinami M, et al. Five-year analysis of adjuvant dabrafenib plus trametinib in Stage III melanoma. N Engl J Med. 2020;383:1139–48.

    Article  CAS  Google Scholar 

  2. Eggermont AM, Blank CU, Mandalà M, et al. Adjuvant pembrolizumab versus placebo in resected stage III melanoma (EORTC 1325-MG/KEYNOTE-054): distant metastasis-free survival results from a double-blind, randomised, controlled, phase 3 trial. Lancet Oncol. 2021;22:643–54.

    Article  CAS  Google Scholar 

  3. Menzies AM, Amaria RN, Rozeman EA, et al. Pathological response and survival with neoadjuvant therapy in melanoma: a pooled analysis from the International Neoadjuvant Melanoma Consortium (INMC). Nat Med. 2021;27:301–9.

    Article  CAS  Google Scholar 

  4. Hieken TJ, Price DL, Piltin MA, et al. Surgeon assessment of the technical impact of neoadjuvant systemic therapy on operable stage III melanoma. Ann Surg Oncol. 2021. https://doi.org/10.1245/s10434-021-11112-9.

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Tina J. Hieken MD.

Ethics declarations

Disclosures

Tina Hieken - Research funding supporting to my institution supporting this work from Genentech. Unrelated research funding from SkylineDX. Matthew Block - Institutional research support for the project leading to the manuscript was provided by Genentech; Institutional research support from Merck and Bristol-Myers Squibb.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Hieken, T.J., Piltin, M.A. & Block, M.S. ASO Author Reflections: Adding Value to Multidisciplinary Care by Incorporating Structured Surgeon Survey Assessment of the Effect of Neoadjuvant Therapies on Melanoma Operations. Ann Surg Oncol 29, 787–788 (2022). https://doi.org/10.1245/s10434-021-11117-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1245/s10434-021-11117-4

Navigation